发明名称 RNAi PROBE TARGETING CANCER-RELATED PROTEIN
摘要 <P>PROBLEM TO BE SOLVED: To provide a method for using RNAi sequences in the treatment of cancers of various types, including prostate cancer, sarcomas such as osteosarcoma, renal cell carcinoma, breast cancer, bladder cancer, lung cancer, colon cancer, ovarian cancer, anaplastic large cell lymphoma and melanoma, and Alzheimer's disease, and to provide a method for treating individual, including human individual in need of such treatment by administering an RNA molecule having RNAi activity. <P>SOLUTION: The invention relates to the RNAi sequences useful as therapeutics in the treatment of cancers of various types, including prostate cancer, sarcomas such as osteosarcoma, renal cell carcinoma, breast cancer, bladder cancer, lung cancer, colon cancer, ovarian cancer, anaplastic large cell lymphoma and melanoma, and Alzheimer's disease. These sequences target clusterin, IGFBP-5, IGFBP-2, both IGFBP-2 and IGFBP-5 simultaneously, Mitf, and B-raf. <P>COPYRIGHT: (C)2010,JPO&INPIT
申请公布号 JP2010193908(A) 申请公布日期 2010.09.09
申请号 JP20100128382 申请日期 2010.06.04
申请人 UNIV OF BRITISH COLUMBIA 发明人 JANSEN BURKHARD;GLEAVE MARTIN E;SIGNAEVSKY MAXIM;BERALDI ELIANA;TROUGAKOS IOANNIS P;GONOS EFSTATJIOS S
分类号 C12N15/113;A61K31/712;A61K31/713;A61K38/00;A61K48/00;A61P25/28;A61P35/00 主分类号 C12N15/113
代理机构 代理人
主权项
地址